Showing 1 - 15 results of 15 for search '"typhoid fever"', query time: 0.08s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study by Birger, R, Antillón, M, Bilcke, J, Dolecek, C, Dougan, G, Pollard, AJ, Neuzil, KM, Frost, I, Laxminarayan, R, Pitzer, VE

    Published 2022
    “…<strong>Background<br></strong> Multidrug resistance and fluoroquinolone non-susceptibility (FQNS) are major concerns for the epidemiology and treatment of typhoid fever. The 2018 prequalification of the first typhoid conjugate vaccine (TCV) by WHO provides an opportunity to limit the transmission and burden of antimicrobial-resistant typhoid fever. …”
    Journal article
  5. 5

    A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data by Phillips, MT, Meiring, JE, Voysey, M, Warren, JL, Baker, S, Basnyat, B, Clemens, JD, Dolecek, C, Dunstan, SJ, Dougan, G, Gordon, MA, Thindwa, D, Heyderman, RS, Holt, KE, Qadri, F, Pollard, AJ, Pitzer, VE

    Published 2021
    “…Decisions about typhoid fever prevention and control are based on estimates of typhoid incidence and their uncertainty. …”
    Journal article
  6. 6

    A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. by Dolecek, C, Tran, T, Nguyen, N, Le, T, Ha, V, Phung, Q, Doan, C, Nguyen, T, Duong, T, Luong, B, Nguyen, T, Nguyen, T, Pham, N, Mai, N, Phan, V, Vo, A, Nguyen, V, Tran, T, Tran, T, Schultsz, C, Dunstan, S, Stepniewska, K, Campbell, J, To, S, Basnyat, B, Nguyen, V, Nguyen, V, Nguyen, T, Tran, T, Farrar, J

    Published 2008
    “… BACKGROUND: Drug resistant typhoid fever is a major clinical problem globally. Many of the first line antibiotics, including the older generation fluoroquinolones, ciprofloxacin and ofloxacin, are failing. …”
    Journal article
  7. 7
  8. 8

    Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocol by Giri, A, Karkey, A, Dongol, S, Arjyal, A, Maharjan, A, Veeraraghavan, B, Paudyal, B, Dolecek, C, Gajurel, D, Phuong, DNT, Thanh, DP, Qamar, F, Kang, G, Hien, HV, John, J, Lawson, K, Wolbers, M, Hossain, MS, Sharifuzzaman, M, Luangasanatip, N, Maharjan, N, Olliaro, P, Rupali, P, Shakya, R, Shakoor, S, Rijal, S, Qureshi, S, Baker, S, Joshi, S, Ahmed, T, Darton, T, Bao, TN, Lubell, Y, Kestelyn, E, Thwaites, G, Parry, C, Basnyat, B

    Published 2021
    “…Patients with suspected uncomplicated typhoid fever will be randomized to one of the two interventions: Arm A: azithromycin 20mg/kg/day oral dose once daily (maximum 1gm/day) and cefixime 20mg/kg/day oral dose in two divided doses (maximum 400mg bd) for 7 days, Arm B: azithromycin 20mg/kg/day oral dose once daily (max 1gm/day) for 7 days AND cefixime-matched placebo for 7 days. …”
    Journal article
  9. 9
  10. 10

    Temporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of Vietnam. by Holt, K, Dolecek, C, Chau, T, Duy, P, La, T, Hoang, N, Nga, T, Campbell, J, Manh, B, Vinh Chau, N, Hien, T, Farrar, J, Dougan, G, Baker, S

    Published 2011
    “… BACKGROUND: typhoid fever remains a public health problem in Vietnam, with a significant burden in the Mekong River delta region. …”
    Journal article
  11. 11

    Temporal fluctuation of multidrug resistant Salmonella Typhi haplotypes in the Mekong River delta region of Vietnam by Holt, K, Dolecek, C, Chau, T, Duy, P, La, T, Hoang, N, Nga, T, Campbell, J, Manh, B, Chau, N, Hien, T, Farrar, J, Dougan, G, Baker, S

    Published 2011
    “…<p>Background: Typhoid fever remains a public health problem in Vietnam, with a significant burden in the Mekong River delta region. …”
    Journal article
  12. 12

    Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. by Thompson, L, Dunstan, S, Dolecek, C, Perkins, T, House, D, Dougan, G, Nguyen, T, Tran, T, Doan, C, Le, T, Nguyen, T, Tran, T, Farrar, J, Monack, D, Lynn, D, Popper, S, Falkow, S

    Published 2009
    “…We used microarrays and transcriptional profiling of peripheral blood to investigate the host response of 29 individuals who contracted typhoid fever in the Mekong Delta region of Vietnam. …”
    Journal article
  13. 13

    The microbiological and clinical characteristics of invasive salmonella in gallbladders from cholecystectomy patients in kathmandu, Nepal by Dongol, S, Thompson, C, Clare, S, Nga, T, Duy, P, Karkey, A, Arjyal, A, Koirala, S, Khatri, N, Maskey, P, Poudel, S, Jaiswal, V, Vaidya, S, Dougan, G, Farrar, J, Dolecek, C, Basnyat, B, Baker, S

    Published 2012
    “…Gallbladder carriage of invasive Salmonella is considered fundamental in sustaining typhoid fever transmission. Bile and tissue was obtained from 1,377 individuals undergoing cholecystectomy in Kathmandu to investigate the prevalence, characteristics and relevance of invasive Salmonella in the gallbladder in an endemic area. …”
    Journal article
  14. 14
  15. 15

    Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study... by Browne, AJ, Chipeta, MG, Fell, FJ, Haines-Woodhouse, G, Kashef Hamadani, BH, Kumaran, EAP, Robles Aguilar, G, McManigal, B, Ashley, EA, Basnyat, B, Chansamouth, V, Dunachie, SJ, Henry, NJ, Karkey, A, Mayxay, M, Newton, PN, Phommasone, K, Pokharel, S, Pollard, AJ, Roberts, T, Shakya, M, Turner, C, Day, NPJ, Sartorius, B, Dolecek, C

    Published 2024
    “…Our analysis highlights the increasing levels of AMR in this preventable infection and serves as a resource to guide urgently needed public health interventions, such as improvements in water, sanitation, and hygiene and typhoid fever vaccination campaigns.</p> <p><strong>Funding</strong> Fleming Fund, UK Department of Health and Social Care; Wellcome Trust; and Bill and Melinda Gates Foundation.…”
    Journal article